Related Experiment Video
Updated: May 12, 2026

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Published on: December 28, 2017
Radiation Necrosis in Pediatric Proton Therapy for Central Nervous System Tumors: Current Evidence and Future
Taha Kassim Dohadwala1, Soumiya Nadar2, Arusha Ayub3
1Department of Medicine, David Tvildiani Medical University, Tbilisi, Georgia.
Insights
Radiation necrosis (RN) is a serious complication of pediatric proton beam therapy (PBT). Understanding its risk factors, imaging, and management is vital for balancing tumor control and neurocognitive function.
Area of Science:
- Pediatric Oncology
- Radiation Oncology
- Neurology
Background:
- Radiation necrosis (RN) is a significant late complication following central nervous system irradiation in children.
- Proton beam therapy (PBT) is increasingly used to minimize normal-tissue exposure, necessitating a deeper understanding of RN.
- Factors influencing RN incidence in pediatric PBT include tumor characteristics, dose-volume parameters, follow-up duration, and linear energy transfer (LET).
Purpose of the Study:
- To review and synthesize current knowledge on risk factors, imaging evaluation, and management of radiation necrosis in pediatric patients treated with proton beam therapy.
- To highlight the unique considerations of PBT, such as elevated LET, in the context of RN.
- To emphasize the need for improved risk prediction and management strategies.
Main Methods:
- Review of existing literature on radiation necrosis following pediatric proton beam therapy.
- Analysis of reported incidence rates and associated risk factors.
- Evaluation of advanced magnetic resonance imaging (MRI) techniques for differentiating RN from tumor progression.
- Summary of current management strategies.
Main Results:
- RN incidence following pediatric PBT varies and is influenced by tumor specifics, dose-volume metrics, follow-up length, younger age, chemotherapy, and peritumoral white-matter dose.
- Elevated LET may present a unique risk profile compared to photon therapy.
- Advanced MRI techniques aid in distinguishing RN from progression, though accuracy is not perfect.
- Management options include corticosteroids, bevacizumab, hyperbaric oxygen, and surgery.
Conclusions:
- Understanding RN in pediatric PBT is crucial for optimizing treatment outcomes and preserving neurocognitive function.
- Prioritizing LET-aware planning, vigilant imaging surveillance, and prospective studies with radiogenomic profiling is essential for improved risk prediction and management.
- Further research is needed to refine strategies for managing RN and enhancing long-term quality-of-life in pediatric patients.
Abstract:
Radiation necrosis (RN) is a clinically significant late complication of central nervous system irradiation in pediatric patients. With the increasing use of proton beam therapy (PBT) to reduce normal-tissue exposure, understanding RN risk factors, imaging evaluation, and management has become crucial. Reported incidence of RN following pediatric PBT varies considerably across studies and appears influenced by tumor characteristics, dose-volume parameters, and duration of follow-up. Elevated linear energy transfer (LET) and variable relative biological effectiveness at the distal beam edge may confer a unique risk compared with photon therapy. Additional risk factors include younger age, concurrent chemotherapy, and higher peritumoral white-matter dose. Advanced magnetic resonance imaging, including perfusion, diffusion, and spectroscopy, improves differentiation of RN from progression but lacks perfect accuracy. Management strategies include corticosteroids, bevacizumab, hyperbaric oxygen, and surgery for refractory cases. Incorporating LET-aware planning, vigilant imaging surveillance, and prospective multicenter studies with radiogenomic profiling should be prioritized to improve risk prediction and optimize management. Understanding RN in the context of pediatric PBT is essential to balance tumor control with preservation of neurocognitive function and long-term quality-of-life.
More Related Videos
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022